毫米波辐射对植入前小鼠胚胎及早期胚胎的影响

本文报道小鼠受精卵体外及在体受毫米波辐照后一些改变。毫米波源为36.11GHz固态微波连续发生器,波长8mm,功率密度为10mW/cm~2、8mW/cm~2、4mW/cm~2及2mW/cm~2。结果发现2-4mW/cm~2毫米波辐照即可使体外培养之受精卵细胞表面微绒毛减少、脱落,细胞表面形成许多囊泡。透射电镜下可见细胞间隙扩大、胞浆中线粒体膨胀、空化,用FITC-ConA试验可见细胞表面结合荧光减少。酶试验证明辐照后卵胚细胞表面AKP,ATPase,5′-Nase均有降低。在体受精卵细胞经辐射后证明,辐射可使胎儿体重增长减慢,囊胚形成数量下降,植入率降低,而表面酶下降不明显。     

Effects of EGF and bFGF on Irradiated Parotid Glands

Radiotherapy is common treatment for head-and-neck cancer, during which the salivary glands are often included within the radiation field. The most common side effect of this treatment is the development of oral dryness (xerostomia). This study considers the administration of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF or FGF2) at physiological concentrations before and after irradiation in order to repair radiation-induced damage in salivary gland cells. As a preliminary examination of the efficacy of this approach we have characterized the effects of EGF and bFGF on the apoptotic response of 15-Gy irradiated rat salivary glands in vitro. Also, we have developed a controlled-release delivery system to effectively administer the growth factor to the gland since local delivery is essential to avoid unwanted protection of cancer cells. In vitro administration of bFGF prior to and immediately after irradiation partially protected (44%) the rat parotid gland. EGF did not show any significant radioprotective effect on parotid glands after a single 15-Gy irradiation dose. Encapsulation, storage and release of bFGF from biodegradable 50/50 PLGA microspheres did not affect the functionality of the growth factor in vitro.     

γ射线低温辐照对胶原膜体外稳定性和细胞相容性的影响

低温下,胶原膜经γ射线辐照改性,采用剂量率为22 KG y/h,辐照剂量分别为15、25、35 KG y。测定辐照前后胶原膜抗胶原酶酶解能力,对胶原膜的体外稳定性进行了初步评价,结合红外光谱分析对辐照改性机理进行了探讨。结果表明,在实验所设计的条件下,辐照改性后胶原膜的交联度及稳定性均增加。采用M TT法结合扫描电镜观察,对辐照后胶原膜的细胞相容性进行了研究,表明在一定的辐照剂量范围内(<25 KG y),辐照对胶原膜的细胞相容性没有明显的影响。当超过一定剂量后,辐照改性将在一定程度上影响胶原膜的细胞相容性。     

Fetoscopic photography

Fetoscopic visualization may be used for the prenatal diagnosis of external structural malformations of the fetus. Objective documentation of these fetoscopic findings would be desirable. The photographic equipment and techniques required for fetoscopic photography have been investigated, and the results of these investigations with standard fetoscopic instruments in current clinical usage are described. The factors evaluated include the light source, camera equipment, camera settings and film.     

蝎毒多肽对辐射损伤小鼠骨髓造血干细胞及祖细胞的作用

目的探讨不同蝎毒多肽(scorpion venom peptide,SVP)组分对辐射后机体造血干细胞及祖细胞恢复的作用。方法6.0GyX射线一次性全身照射,制作辐射损伤小鼠模型。内源性脾结节法观察照射后第10天脾集落形成单位(CFU-S)的变化。用甲基纤维素半固体培养基培养骨髓混合集落生成单位(CFU-Mix),观察体内外给药方法及照射后不同时间对CFU-Mix生成的影响。结果(1)体内实验:SVPⅣ组分处理后的CFU-S数明显高于照射对照组(P<0.05);SVPⅤ组分CFU-S数量与照射对照组差异无统计学意义。照射后各SVP组CFU-Mix的数量均高于照射对照组,差异有统计学意义(P<0.05)。(2)体外实验:与照射对照组相比,体外分别单独加入SVPⅣ、Ⅴ组分以及细胞因子(IL-6和SCF)均能够促进CFU-Mix的增殖;而SVPⅣ、Ⅴ组分分别与细胞因子联合应用对CFU-Mix生成的促进作用更为明显,其中Ⅳ组分效果更强,与照射对照组相比差异均有统计学意义(P<0.05)。结论SVP具有保护辐射损伤小鼠造血干细胞及祖细胞,加速其增殖能力恢复的作用。     

Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy

The expression of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)2 in the irradiated brain was examined to test how a single high dose radiation, similar to that used for intraoperative radiation therapy given to the normal cerebrum, can affect the vascular endothelium. After a burr hole trephination in the rat skull, the cerebral hemisphere was exposed to a single 10 Gy dose of gamma rays, and the radiation effect was assessed at 1, 2, 4, 6, and 8 weeks after irradiation. Histological changes, such as reactive gliosis, inflammation, vascular proliferation and necrosis, were correlated with the duration after irradiation. Significant VEGF and FGF2 expression in the 2- and 8-week were detected by enzyme-linked immunosorbent assay quantification in the radiation group. Immunohistochemical study for VEGF was done and the number of positive cells gradually increased over time, compared with the sham operation group. In conclusion, the radiation injuries consisted of radiation necrosis associated with the expression of VEGF and FGF2. These findings indicate that VEGF and FGF2 may play a role in the radiation injuries after intraoperative single high-dose irradiation.     

近场射频辐射条件下大白鼠共振吸收频率的研究

在Ｅ极化、辐射电平１ｍｗ／ｃｍ２条件下，在４０．６８ＭＨｚ～４ＧＨｚ频段内６个频率点上，利用红外热图术观察了６０只Ｗｉｓｔａｒ成年大白鼠，连续辐射１ｈ后，体表及各部位体表温度变化。结果表明，体表温度与肛温变化有很好的一致性，并在１．５ＧＨｚ有最大值。它表明在该频率下，实验鼠吸收射频能量最大，表现出明显的谐振吸引特性。     

Radiation therapy for pancreatic cancer: eleven year experience at the JCRT

Radiation therapy (XRT) for 41 patients with unresectable pancreatic cancer resulted in a median survival of 7.0 months. There was no difference in median survival for patients receiving external beam alone (3500 to 5600 cGy) (n = 28), intraoperative (IORT) boost plus external beam (5040 to 6750 cGy) (n = 9), or a gold-198 implant +/- external beam radiation (n = 4). A pilot study using orthovoltage IORT boost indicates no acute toxicity with doses of 1250 to 1750 cGy. Serious late damage has not been observed in any patients followed to 2 years. Local recurrence in patients treated post-operatively after "radical" surgery occurred in one of 10 (10%). This adjuvant treatment is safe and appears to improve local control rates compared to historical data, but survival is still poor. The median survival for the post-operative group is 10 months; three patients are alive without disease 8 months to 8.3 years after treatment.     

The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodies

We studied the influence of radiation therapy on lymphocyte subpopulations in 17 patients undergoing adjuvant radiation therapy for primary breast cancer, and eight patients receiving brachytherapy and external beam irradiation for primary cancer of the uterus. Radiation therapy reduced B- and T-lymphocytes in proportion to the total lymphocyte population so that their percentages remained unchanged. Determination of helper and suppressor T-lymphocytes before, during and 6 months after completion of radiotherapy revealed that in both groups of patients suppressor T-lymphocytes were more resistant to and recovered faster after radiotherapy. This resulted in a decline of the "immunoregulatory balance" (helper/suppressor ratio). Although this ratio had been higher in both groups of patients than in healthy age- and sex-matched controls before therapy, it became normal and subnormal during and after radiotherapy. The clinical significance of the differential influence of radiotherapy on T-lymphocyte subpopulations remains to be determined.     

The effect of lucanthone on sublethal radiation damage, in vivo

The capacity of the Chinese hamster jejunal crypt cell to accumulate and repair sublethal radiation damage was determined by analyzing the return of the shoulder of the radiation dose-crypt microcolony survival curve (Dr) after a priming dose of 1250 rad. The control split dose crypt cell survival curve exhibited a D0, Dr and "n" of 179 +/- 3 rad, 261 +/- 3 rad and 4.3 respectively; repair of sublethal radiation damage was completed by two hours post-irradiation. The effect of lucanthone (an antischistosomal DNA intercalating agent) on the crypt cell's capacity to accumulate and repair sublethal radiation damage was determined by injecting the drug (100 mg/kg, i.p.) at intervals before irradiation with a priming dose of 1250 rad, followed two hours later by graded doses. Injection coincident with the priming dose of radiation resulted in a 22 rad reduction of the Dr (compared to control Dr). Injection eight hours before the priming dose almost completely inhibited the accumulation and repair of sublethal radiation damage so that the resultant Dr two hours later was only 29 rad (a 232 rad reduction). At no time was the D0 of the crypt cell survival curve affected by lucanthone. These data confirm previous results from whole crypt analysis and LD50/7 analysis that non-toxic concentrations of lucanthone reversibly inhibit the accumulation and repair of sublethal radiation damage in a time-dependent manner with complete inhibition approximately eight hours post-injection. This drug is useful for the study of sublethal radiation damage in vivo and may be beneficial in radiation therapy of cancer when it is desirable to inhibit the repair of sublethal radiation damage.